Search

The finishing operation completes the manufacturing cycle of a component. Depending on the level of finish (micro and nano) required on the component surface, different finishing processes are employed. Several components employed in medical, automotive and chemical industries use different types of passages for the flow of fluid. The surface roughness of such passages decides the functionality of the component. Drug-eluting stents are one of the recent advancements in the medical industry. They possess microholes for release of the drugs to the point of cure. Microholes are mostly fabricated by thermal-based micromachining processes that generate metallurgically destroyed surface layers with high surface roughness. Later, these are polished using chemical or electrochemical polishing techniques, which chemically destroy the quality of the surface. These metallurgically and chemically modified (destroyed/changed) rough surfaces on the microhole wall can cause contamination of the drug. So in this article, microholes of diameter 850 ± 30 µm are fabricated in surgical stainless steel (SS 316L) workpieces using the electric discharge micromachining process. Machined microholes are finished by employing a non-traditional finishing process called the abrasive flow finishing process. Instead of using a commercially available expensive abrasive flow finishing medium, the economic medium is fabricated in-house, and its rheological study is carried out. Machining process produces microholes with a surface roughness of about 1.40 ± 0.10 µm. Later, by finishing of microholes with the abrasive flow finishing process, the surface roughness is reduced to 150 nm (percentage surface roughness improvement of about 88.53%). Therefore, the abrasive flow finishing process is a viable alternative to chemical-based polishing processes as it removes the recast layer and achieves nanosurface roughness. [ABSTRACT FROM AUTHOR]

The current technological advancements in emerging 3D printing technologies are indeed propitious. To date, ground-breaking 3D printing technologies are used in automobile, aerospace, clothing, pharma, and biomedical industries by creating pre-requisite engineered and tailored end-user products reaching standard sets. 3D printing is also becoming a crucial technology in support of enhanced health care and general emergency response since the beginning of the COVID-19 pandemic. As the world is facing a significant lack of medicinal supplies, manufactures are struggling to fulfill demands due to the ongoing COVID-19 pandemic. The decline in the diagnostic testing kits supply chained to increased interest in 3D printed Nasopharyngeal (NP) swabs. This article has reviewed and studied the sensitivity of the NP swabs and various NP swab designs. The process of different 3D printing technologies that are employed to address the swab shortages during COVID-19 is explained in detail. The paper ends with the conclusions drawn from the literature review., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2021 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the International Conference on Materials, Processing & Characterization.)

The current work focuses on the fabrication of high-molecular-weight stereocomplex poly(lactic acid)/nanohydroxyapatite (sPLA/n-HAP)-based bionanocomposite for three-dimensional (3D)-printed orthopedic implants and high-temperature engineering applications. To achieve the same, n-HAP is grafted with poly(d-lactic acid) (PDLA) via in situ ring-opening polymerization of d-lactide, followed by blending with poly(l-lactic acid) (PLLA), which yields sPLA/n-HAP biocomposite with improved storage modulus even at temperatures higher than 140 °C. X-ray diffraction and calorimetric analysis ensure the presence of 100% stereocomplex crystallites of biocomposite along with significant improvement in the melting temperature (∼227 °C). Noteworthy improvements in the mechanical and gas-barrier properties of the developed biocomposites are achieved due to the uniform dispersion of n-HAP (∼60 nm) confirmed by morphological studies. An unusual improvement in elongation at break (∼130% at 1 wt % HAP loading) makes this composite a toughened material. However, the tensile strength is improved by ∼16%, whereas oxygen permeability and water vapor transmission rate are found to reduce by ∼48 and ∼34%, respectively. Interestingly, the developed material is processed as monofilament, followed to 3D printing to yield a middle phalanx bone as a representative example of orthopedic implants. In vitro studies reveal that cell adhesion and proliferation on the surface of the developed biocomposite support its biocompatible nature. This signifies the possible future aspects of the material in commercial biomedical and high-temperature engineering applications., Competing Interests: The authors declare no competing financial interest.